To include your compound in the COVID-19 Resource Center, submit it here.

Celexa citalopram: Phase IV data

Data from the Phase IV STAR*D study in 1,439 evaluable patients, with nonpsychotic major depressive disorder who had no remission of symptoms with citalopram

Read the full 244 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE